Lifestyle intervention improves lipoprotein particle size and distribution without weight loss in obese Latino adolescents

Pediatr Obes. 2013 Oct;8(5):e59-63. doi: 10.1111/j.2047-6310.2013.00162.x. Epub 2013 Apr 10.

Abstract

Childhood obesity is associated with a pro-atherogenic phenotype contributing to increased cardiovascular disease (CVD) risk. This single-arm pilot study examined the effects of a lifestyle intervention on lipoprotein particle size and cholesterol distribution in obese Latino adolescents. Fifteen obese Latino adolescents (15.0 ± 1.0 years) completed a 12-week nutrition education and exercise intervention. Low-density lipoprotein (LDL) particle size and distribution of cholesterol in lipoprotein subclasses were determined via polyacrylamide gel electrophoresis. The intervention resulted in increases in mean LDL particle size (269.3 ± 3.4 to 271.6 ± 2.9 Å, P = 0.0003) and cholesterol in large high-density lipoprotein (HDL) subfractions (22.4 ± 11.2 to 26.8 ± 10.6% area, P = 0.007) along with decreases of cholesterol in small LDL (1.6 ± 2.0 to 0.6 ± 1.2% area, P < 0.01) and HDL subfractions (23.2 ± 9.4 to 19.0 ± 6.7% area, P = 0.05). These improvements were observed independent of changes in weight (90.7 ± 26.2 to 89.9 ± 27.8 kg, P > 0.05) and suggest that lifestyle modification in obese youth may reduce cardiovascular risk by shifting lipoprotein particle size and cholesterol distribution to a less atherogenic phenotype.

Keywords: Atherosclerosis; LDL size; cholesterol distribution; obesity..

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Adolescent
  • Atherosclerosis / blood
  • Atherosclerosis / epidemiology
  • Atherosclerosis / prevention & control*
  • Body Mass Index
  • Body Weight
  • Female
  • Health Education
  • Hispanic or Latino* / statistics & numerical data
  • Humans
  • Lipoproteins / blood*
  • Male
  • Nutritional Status
  • Particle Size*
  • Patient Compliance
  • Pediatric Obesity / blood
  • Pediatric Obesity / epidemiology
  • Pediatric Obesity / prevention & control*
  • Phenotype
  • Pilot Projects
  • Risk Factors
  • Risk Reduction Behavior
  • Triglycerides / blood*
  • Weight Loss

Substances

  • Lipoproteins
  • Triglycerides